| |
|
池田 康夫 |
早稲田大学 特命教授 |
| 血栓止血学 |
Ikeda Y, Shimada K, Teramoto T, Uchiyama S, Yamazaki T, Oikawa S, Sugawara M, Ando K, Murata M, Yokoyama K, Ishizuka N.
Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial.
JAMA. 2014 Dec 17;312(23):2510-20. doi: 10.1001/jama.2014.15690.
|
Ikeda Y, Miyakawa Y: Development of thrombopoietin receptor agonists for clinical use.
J Thromb Haemost 7, 239-244, Sup1, 2009
Ikeda, Y., Handa, M., Kawano, K., Kamata, T., Murata, M., Araki, Y., Ambo, H., Kawai, Y., Watanabe, K., Itagaki, I., Sakai, K., and Ruggeri, Z.M.:
|
The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress.
J. Clin. Invest. 87: 1234-1240, 1991
|
|
| |
|
内野 克喜 |
東京薬科大学 常務理事・特命教授 |
| 医療薬学 |
| Clinical pharmacokinetics and diuretic effect of furosemide in plain tablet and retard capsule with normal subjects and liver cirrhotic patients. Uchino K, Isozaki S, Amano J, Tanaka N, Saitoh Y, Nakagawa F,Tamura Z. J. Pharm. Dyn. 1983; 6: 684-691. |
| 第十一改正調剤指針、増補版 日本薬剤師会編 内野克喜（分担） 薬事日報社（2002） |
| 今日の治療指針 2015年版 医学書院 (2015） |
|
| |
|
長野 哲雄 |
東京大学名誉教授、東京大学創薬機構 客員教授 |
| 薬学 |
| Fluorescent probes for sensing and imaging, Ueno, T, and Nagano, T, Nat. Methods, 8, 642-645, 2011. |
| Bioimaging of nitric oxide, Nagano, T, and Yoshimura, T, Chem. Rev., 102, 1235-1269, 2002. |
| Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins, Kojima, H, Nakatsubo, N, Kikuchi, K, Kawahara, S, Kirino, Y, Nagoshi, N, Hirata, Y, and Nagano, T, Anal. Chem., 70, 2446-2453, 1998. |
|
| |
|
埜中 征哉 |
国立精神・神経センター病院 名誉院長 |
| 神経内科学 |
| Mitsuhashi S, Nonaka I, Wu S, Moreno CA, Shalaby S, Hayashi YK, Noguchi S, Nishino I. Distal myopathy in multi-minicore disease. Intern Med. 2009;48:1759-62. |
| Hayashi YK, Matsuda C, Ogawa M, Goto K, Tominaga K, Mitsuhashi S, Park YE, Nonaka I, Hino-Fukuyo N, Haginoya K, Sugano H, Nishino I. Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy. J Clin Invest. 2009;119:2623-33 |
| Park YE, Hayashi YK, Bonne G, Arimura T, Noguchi S, Nonaka I, Nishino I. Autophagic degradation of nuclear components in mammalian cells. Autophagy. 2009;5:795-804. |
|
| ○ |
|
橋田 充 |
京都大学大学院薬学研究科 教授 |
| 薬物動態学、製剤学 |
| Suppression of experimental arthritis with self-assembling glycol-split heparin nanoparticles via inhibition of TLR4-NF-κB signaling. Babazada H, Yamashita F, and Hashida M: J Control Release. 2014; 194: 295-300. |
| Ultrasound induced cancer immunotherapy. Unga J and Hashida M. Adv Drug Deliv Rev. 2014; 72: 144-153. |
| 「図解で学ぶDDS−薬物治療の最適化を目指す先端創薬技術 第２版」橋田 充 監修・分担執筆、じほう (2016). |
|
| |
|
松木 則夫 |
東京大学、理事・副学長 |
| 薬理学、神経科学、評価科学 |
| Yokota M, Kusama M, Matsuki N and Ono S. Different contributions of internal reviewers and external experts to labelling decisions on therapeutic indications in new drug reviews in Japan. J Clin Pharm Ther. 38:456-61, 2013. |
| Arnold FL, Fukunaga S, Kusama M, Matsuki N, and Ono S. Assessment of Factors Associated With Dose Differences Between Japan and the United States. Clin Pharmacol Ther. 95:542-9, 2014. |
| 松木則夫、レギュラトリーサイエンスと薬理学、日本薬理学雑誌 第146巻、pp197-200、2015年。 |
|
| |
|
安原 一 |
（公財）昭和大学医学・医療振興財団理事長 |
| 臨床薬理学 |
Membrane effects of various drugs on isolated rat hepatocytes and erythrocytes. Yasuhara H, Yonooka M, Kamei K, Sakamoto K. Toxicol Appl Pharmacol. 1985;79:453-460.
|
| Which is more important in pharmacokinetics: Inter-ethnic or Intra-ethnic variability? Session 4: Ethnic factors in acceptability of foreign data. Yasuhara H. Proceeding of The Second International Conference on Harmonization, 436-443, The Queen’s University of Belfast (Northern Ireland) , 1994 |
| 「臨床薬理学」第３版 安原 一他共編 医学書院（２０１１） |
|
